Photo from archive.org
Quadricyclane derivatives are shown for the first time to be promising for application as anticancer drugs. The efficiency of such cage compounds is mainly due to thermal action on cancer… Click to show full abstract
Quadricyclane derivatives are shown for the first time to be promising for application as anticancer drugs. The efficiency of such cage compounds is mainly due to thermal action on cancer cells resulting from a C—C bond cleavage in quadricyclane on exposure to catalytic amounts of cisplatin Pt ions.
Keywords:
new original;
original approach;
anticancer drugs;
approach design;
design anticancer;
anticancer
Journal Title: Russian Chemical Bulletin
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Russian Chemical Bulletin
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!